Search Results 661-670 of 19158 for creatinine

1. Study To Test The Safety And Tolerability Of PF-07257876 In Participants With Selected Advanced Tumors - Mayo Clinic

   Hemoglobin >10 g/dL;. Adequate Renal Function including: Estimated creatinine clearance ≥ 30 mL/min as calculated using the. Cockroft-Gault method. In ...

2. Brentuximab Vedotin and Combination Chemotherapy in Treating Younger Patients with Newly Diagnosed Hodgkin Lymphoma - Mayo Clinic

   Creatinine clearance or radioisotope glomerular filtration rate (GFR) ≥ 70 mL/min/1.73 m^2 or a serum creatinine based on age/gender as follows: 2 to < 6 ...

3. IS-002 In Prostate Cancer - Mayo Clinic

   Creatinine clearance: 2.5 x ULN;; Total Bilirubin (serum): > 1.5 x ULN. Subject has received neo-adjuvant therapy, radiation therapy, focal ablation therapy ...

4. A Study To Evaluate Abemaciclib For Surgically Resectable, Chemotherapy-Resistant, Triple Negative Breast Cancer - Mayo Clinic

   ... creatinine clearance <30ml/min], history of major surgical resection involving the stomach or small bowel, or preexisting Crohn's disease or ulcerative ...

5. A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies

   Serum creatinine ≤ 1.5 mg/dL or a calculated creatinine clearance of ≥ 60 mL/min as determined by the Cockcroft-Gault equation. Female subjects of ...

6. Comparing Combinations Of Drugs To Treat Newly Diagnosed Multiple Myeloma (NDMM) When A Stem Cell Transplant Is Not A Medically Suitable Treatment - Mayo Clinic

   - Kidney dysfunction showing calculated creatinine clearance (CrCl) <30 ml/min. - Actual lab serum creatinine value with a minimum of 0.7 mg/dL. - ...

7. Serum Bovine Immunoglobulin Protein Isolate in Improving Quality of Life and Post-Operative Recovery in Patients With Gynecological Cancer After Undergoing Surgery - Mayo Clinic

   Creatinine ≤ 1.5 x the upper limit of normal (ULN); Absolute neutrophil count ≥ 1500/mm^3; Platelet count ≥ 100,000/mm^3; Ability to complete questionnaire ...

8. Study Of TBio-6517, Given Intratumorally, Alone Or In Combination With Pembrolizumab, In Solid Tumors - Mayo Clinic

   Serum creatinine ≤ 1.5× ULN or creatinine clearance ≥ 60 mL/min for patient with creatinine levels > 1.5 × institutional ULN according to Cockcroft-Gault ...

9. Study Of Ociperlimab In Combination With Tislelizumab In Advanced Solid Tumors - Mayo Clinic

   Serum creatinine ≤ 1.5 x upper limit of normal (ULN) or calculated creatinine clearance (CrCl) ≥ 60 mL/min (Cockcroft-Gault formula);; Serum total ...

10. Adrenocorticotropic Hormone (ACTH) For Frequently Relapsing And Steroid Dependent Nephrotic Syndrome - Mayo Clinic

    ... creatinine ratio ≥2 or Albustix reading of ≥2 for 3 or 5 consecutive days). Exclusion Criteria: Prior treatment with ACTH. Cyclophosphamide or rituximab ...